Skip to content

Improving continuity of patient care across sectors: Introducing the VESPEERA admission and discharge model in primary care practices and hospitals in Germany - Process Evaluation for the registered main study DRKS00014294 (VESPEERA-ProcEva)

Improving continuity of patient care across sectors: Introducing the VESPEERA admission and discharge model in primary care practices and hospitals in Germany - Process Evaluation for the registered main study DRKS00014294 (VESPEERA-ProcEva) - VESPEERA-ProcEva

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00015183
Enrollment
905
Registered
2018-08-23
Start date
2018-09-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Processes of admission and discharge management for patients before and after hospital stays

Interventions

Group 1: The VESPEERA process evaluation uses a mixed-methods design and contains qualitative data from interviews as well as quantitative data from questionnaires, hospitals' implementation plans and

Sponsors

Universitätsklinikum Heidelberg - Abteilung Allgemeinmedizin und Versorgungsforschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who take part and gave their informed consent to the VESPEERA study participation and outcomes evaluation can participate in the process evaluation. General practitioners (GPs) and VERAHs from participating GP-practices, who participate in the VESPEERA study and who took part in the kick-off training can participate in the process evaluation. Hospital staff from participating hospitals has to work in one of the departments selected for VESPEERA implementation OR have to be involved in the implementation process of the VESPEERA intervention components on a higher hierarchical level. Furthermore staff from non-participating hospitals and GP-practices will be asked for participation in interviews. All participants should meet the inclusion criteria of the VESPEERA study: they have to be 18 years and older, have written and spoken German language skills and have to be able to give their informed consent into study participation in the process evaluation.

Exclusion criteria

Exclusion criteria: Persons who do not meet the inclusion criteria or who are unable to give their consent are excluded from study participation.

Design outcomes

Primary

MeasureTime frame
1.Was the intervention implemented as planned (“intervention fidelity”) in targeted populations (‘’reach’’)? a.To what extent have the planned components been offered to care providers and patients? b.To what extent have these been utilized by care providers and patients? c.What was the adherence concerning the recommended practices of hospital admission and discharge. d.Has the targeted patient population been reached?

Secondary

MeasureTime frame
2.Which results, from the view point of care providers and patients, were a.Achieved as intended? b.Not achieved although intended? c.Achieved although not intended (positive or negative)? 3.Which components and aspects of the intervention program contributed to achieving the results from the view point of care providers? 4.What were acceptability and attractiveness of the program from the point of view of care providers? 5.a) What are determinants for implementing the program? b) Which contextual factors on system, hospital and practice level influenced the adoption of intervention components and outcomes of the program? 6.Which practices concerning admission and discharge management have been implemented in non-participating hospitals during the intervention phase (for example in consequence of the “Rahmenvertrag über ein Entlassmanagement nach Krankenhausbehandlung”)? 7.Which associations exist between the outcomes and findings of the process evaluation?

Countries

Germany

Contacts

Public ContactJohanna Forstner

Universitätsklinikum HeidelbergAbteilung Allgemeinmedizin und Versorgungsforschung

johanna.forstner@med.uni-heidelberg.de062215635559

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 23, 2026